Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hyperthermia in the treatment of high-risk soft tissue sarcomas: a systematic review.
Veltsista PD, Oberacker E, Ademaj A, Corradini S, Eckert F, Flörcken A, Kaul D, Lindner LH, Issels R, Ott OJ, Pink D, Potkrajcic V, Reichardt P, Roohani S, Spalek MJ, Riesterer O, Zips D, Ghadjar P. Veltsista PD, et al. Among authors: ott oj. Int J Hyperthermia. 2023;40(1):2236337. doi: 10.1080/02656736.2023.2236337. Int J Hyperthermia. 2023. PMID: 37468132 Free article. Review.
Chemoradiotherapy plus hyperthermia (CRTH) versus chemoradiotherapy (CRT) alone in neoadjuvant treatment of soft tissue sarcoma: tumor response, treatment toxicity and disease control.
Willner A, Agaimy A, Fechner K, Ott O, Denz A, Weissmann T, Meidenbauer N, Höfler D, Gaipl U, Frey B, Schmidt M, Haller F, Horch R, Hartmann A, Grützmann R, Fietkau R, Semrau S. Willner A, et al. Int J Hyperthermia. 2023;40(1):2248424. doi: 10.1080/02656736.2023.2248424. Int J Hyperthermia. 2023. PMID: 37611915 Free article.
Regional hyperthermia for soft tissue sarcoma - a survey on current practice, controversies and consensus among 12 European centers.
Roohani S, Ehret F, Beck M, Veltsista DP, Nadobny J, Zschaeck S, Abdel-Rahman S, Eckert F, Flörcken A, Issels RD, Klöck S, Krempien R, Lindner LH, Notter M, Ott OJ, Pink D, Potkrajcic V, Reichardt P, Riesterer O, Spałek MJ, Stutz E, Wessalowski R, Zilli T, Zips D, Ghadjar P, Kaul D. Roohani S, et al. Among authors: ott oj. Int J Hyperthermia. 2024;41(1):2342348. doi: 10.1080/02656736.2024.2342348. Epub 2024 Apr 23. Int J Hyperthermia. 2024. PMID: 38653548 Free article.
Surgical and oncological outcome after extended lymph node dissection for carcinoma of the stomach and the esophagogastric junction: a retrospective analysis from an experienced single center.
Raptis D, Maak M, Krautz C, Merkel S, Brunner M, Agaimy A, Hartmann A, Semrau S, Ott O, Rainer F, Siebler J, Grützmann R, Hohenberger W, Schildberg CW. Raptis D, et al. Arch Med Sci. 2021 Dec 14;20(1):124-132. doi: 10.5114/aoms/141165. eCollection 2024. Arch Med Sci. 2021. PMID: 38414452 Free PMC article.
Accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy compared with whole-breast irradiation with boost for early breast cancer: 10-year results of a GEC-ESTRO randomised, phase 3, non-inferiority trial.
Strnad V, Polgár C, Ott OJ, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, Łyczek J, Guinot JL, Gutierrez Miguelez C, Slampa P, Allgäuer M, Lössl K, Polat B, Fietkau R, Schlamann A, Resch A, Kulik A, Arribas L, Niehoff P, Guedea F, Dunst J, Gall C, Uter W; Groupe Européen de Curiethérapie and European Society for Radiotherapy and Oncology. Strnad V, et al. Among authors: ott oj. Lancet Oncol. 2023 Mar;24(3):262-272. doi: 10.1016/S1470-2045(23)00018-9. Epub 2023 Feb 1. Lancet Oncol. 2023. PMID: 36738756 Clinical Trial.
Cell-In-Cell Structures in Early Breast Cancer Are Prognostically Valuable.
Bauer MF, Hildebrand LS, Rosahl MC, Erber R, Schnellhardt S, Büttner-Herold M, Putz F, Ott OJ, Hack CC, Fietkau R, Distel L. Bauer MF, et al. Among authors: ott oj. Cells. 2022 Dec 24;12(1):81. doi: 10.3390/cells12010081. Cells. 2022. PMID: 36611874 Free PMC article.
Low-dose radiotherapy of osteoarthritis: from biological findings to clinical effects-challenges for future studies.
Weissmann T, Rückert M, Putz F, Donaubauer AJ, Hecht M, Schnellhardt S, Schubert P, Roesch J, Höfler D, Ott OJ, Haderlein M, Lettmaier S, Fietkau R, Frey B, Gaipl US, Deloch L. Weissmann T, et al. Among authors: ott oj. Strahlenther Onkol. 2023 Dec;199(12):1164-1172. doi: 10.1007/s00066-022-02038-6. Epub 2023 Jan 5. Strahlenther Onkol. 2023. PMID: 36602569 Free PMC article. Review.
83 results